- Trials with a EudraCT protocol (32)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (3)
32 result(s) found for: Manometry.
Displaying page 1 of 2.
| EudraCT Number: 2013-004939-73 | Sponsor Protocol Number: LINACLOTIDEPLACEBO | Start Date*: 2014-05-13 |
| Sponsor Name:KULEUVEN | ||
| Full Title: A RANDOMISED, PLACEBO-CONTROLLED, CROSSOVER STUDY TO EVALUATE THE EFFECT OF LINACLOTIDE ON COLONIC MOTILITY ASSESSED WITH INTRALUMINAL COLONIC MANOMETRY IN HEALTHY SUBJECTS | ||
| Medical condition: COLONIC MOTILITY WILL BE STUDIED IN HEALTHY SUBJECTS | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: BE (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2019-002182-35 | Sponsor Protocol Number: buspirone2019 | Start Date*: 2019-09-10 |
| Sponsor Name:KU Leuven - TARGID | ||
| Full Title: The effect of oral buspirone hydrochloride on esophageal motility, bolus transit and symptoms of dysphagia, in patients with poor esophageal motility: A randomized, double-blind, placebo controlle... | ||
| Medical condition: Patients with complaints of dysphagia and poor esophageal motility | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: BE (Trial now transitioned) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2021-000593-29 | Sponsor Protocol Number: CHUBX2020/64 | Start Date*: 2021-06-17 |
| Sponsor Name:CHU DE BORDEAUX | ||
| Full Title: A Prospective Pilot Study to assess the efficacy of BOTOX-A in patients with Low Anterior Resection syndrome (LARS>20) and refractory medical treatment after rectal resection | ||
| Medical condition: Low Anterior Resection syndrome (LARS>20) and refractory medical treatment after rectal resection | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: FR (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2011-002745-35 | Sponsor Protocol Number: rum_baclofen2011 | Start Date*: 2011-09-09 | ||||||||||||||||
| Sponsor Name:UZLeuven | ||||||||||||||||||
| Full Title: A placebo controlled trial with Baclofen for the treatment of patients with clinical suspicion of rumination syndrome or esophageal belching | ||||||||||||||||||
| Medical condition: Rumination syndrome and supragastric belching | ||||||||||||||||||
|
||||||||||||||||||
| Population Age: Adults | Gender: Male, Female | |||||||||||||||||
| Trial protocol: BE (Completed) | ||||||||||||||||||
| Trial results: View results | ||||||||||||||||||
| EudraCT Number: 2005-003759-11 | Sponsor Protocol Number: FI 1 | Start Date*: 2007-03-09 |
| Sponsor Name:BKH Schwaz | ||
| Full Title: Autologous myoblasts for treatment of anal incontinence due to anal sphincter defects | ||
| Medical condition: Fecal (anal) inconinence caused by ruptures/ traumas of the external anal sphincter | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Female | |
| Trial protocol: AT (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2010-018298-39 | Sponsor Protocol Number: botox2010 | Start Date*: 2010-02-15 | |||||||||||
| Sponsor Name:UZLeuven | |||||||||||||
| Full Title: Prospective Randomised Double-blind Sham Study on the Use of Botox for the Treatment of Diffuse esophageal spasm | |||||||||||||
| Medical condition: the effect of Botox on symptoms and manometry patterns in patients with diffuse esophageal spasm. | |||||||||||||
|
|||||||||||||
| Population Age: Adults | Gender: Male, Female | ||||||||||||
| Trial protocol: BE (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2019-002185-13 | Sponsor Protocol Number: clebopride2019 | Start Date*: 2019-10-03 |
| Sponsor Name:KU Leuven - TARGID | ||
| Full Title: A Randomized, Double Blind, Placebo Controlled, Crossover Trial of Clebopride vs Placebo in the Treatment of Clinically Suspected Rumination. | ||
| Medical condition: rumination syndrome | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: BE (Trial now transitioned) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2019-002187-26 | Sponsor Protocol Number: neostigmine2019 | Start Date*: 2019-08-28 |
| Sponsor Name:KU Leuven - TARGID | ||
| Full Title: A Prospective evaluation of the effect of a single dose of neostigmine in patients with patients with weak or absent esophageal peristalsis | ||
| Medical condition: Patients with complaints of dysphagia and poor esophageal motility | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: BE (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2017-002679-25 | Sponsor Protocol Number: S60420 | Start Date*: 2017-09-12 |
| Sponsor Name:KU Leuven | ||
| Full Title: Characterization of colonic motility patterns in different functional bowel disorders compared to health and their role in moving content | ||
| Medical condition: Functional bowel disorders; irritable bowel syndrome (constipation, diarrhea and mixed), chronic constipation, and chronic diarrhea. | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: BE (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2010-021390-36 | Sponsor Protocol Number: buspar2010 | Start Date*: 2010-09-07 |
| Sponsor Name:uzleuven | ||
| Full Title: The Effect of Acute Intake of Oral Buspirone Hydrochloride on Esophageal Motility, Bolus Transit and Symptoms of Dysphagia, in Patients with Ineffective Esophageal Motility: A Pilot, Open-label, Si... | ||
| Medical condition: Ineffective Esophageal Motility | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: BE (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2013-002705-65 | Sponsor Protocol Number: PrucaloprideGastro1 | Start Date*: 2013-09-26 |
| Sponsor Name:TARGID | ||
| Full Title: The effect of Prucalopride (Resolor) on gastric motor function and gastric sensitivity | ||
| Medical condition: Functional dyspepsia | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: BE (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2017-002349-30 | Sponsor Protocol Number: cod2017 | Start Date*: 2017-09-12 |
| Sponsor Name:TARGID, KU Leuven | ||
| Full Title: Effect of codeine on pharyngeal and esophageal motility in healthy subjects: a double-blind, placebo-controlled, randomized, cross-over study | ||
| Medical condition: we will investigate the effect of codeine on motility in the pharynx and esophagus in healthy subjects | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: BE (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2010-019072-68 | Sponsor Protocol Number: version 1 (07/10/2010) | Start Date*: 2010-12-31 |
| Sponsor Name:Guy's & St Thomas' NHS Foundation Trust | ||
| Full Title: A randomised, double blind, crossover study to determine the mechanism of action of Gaviscon Advance in Gastro-Oesophageal Reflux Disease (GORD) | ||
| Medical condition: Gastro-oesophageal reflux disease (GORD) | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: GB (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2017-001216-11 | Sponsor Protocol Number: FISAN-BOT-2017-01 | Start Date*: 2017-04-25 |
| Sponsor Name:Dra. A. Teresa Calderón Duque | ||
| Full Title: Usefulness of botulinum toxin type A in the treatment of chronic anal fissure | ||
| Medical condition: Chronic anal fissure | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: ES (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2021-002288-24 | Sponsor Protocol Number: Ci-FCP001 | Start Date*: 2021-08-10 |
| Sponsor Name:Amsterdam UMC | ||
| Full Title: Effect of citalopram on chest pain in patients with functional chest pain | ||
| Medical condition: Chest pain can be divided in cardiac or non-cardiac chest pain (NCCP). To establish the diagnosis NCCP, acute coronary disease has to be ruled out first. NCCP can be caused by functional chest pain... | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: NL (Prematurely Ended) | ||
| Trial results: View results | ||
| EudraCT Number: 2020-004723-17 | Sponsor Protocol Number: UZBSK001 | Start Date*: 2021-02-26 |
| Sponsor Name:UZ Brussel | ||
| Full Title: Clinical usefulness and influence on oesophageal motility of pyridostigmine for dysphagia in systemic sclerosis. | ||
| Medical condition: Dysphagia by patients suffering from systemic sclerosis | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: BE (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2015-005786-23 | Sponsor Protocol Number: XCEL-SCI-01 | Start Date*: 2016-04-20 | |||||||||||
| Sponsor Name:Banc de Sang i Teixits | |||||||||||||
| Full Title: A phase I/IIa, randomized, double-blind, single-dose, placebo controlled, two-way crossover clinical trial to assess the safety and to obtain efficacy data in intrathecal administration of expanded... | |||||||||||||
| Medical condition: Chronic traumatic spinal cord injury | |||||||||||||
|
|||||||||||||
| Population Age: Adults | Gender: Male, Female | ||||||||||||
| Trial protocol: ES (Ongoing) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2012-002495-13 | Sponsor Protocol Number: SPD555-403 | Start Date*: 2013-01-14 |
| Sponsor Name:Shire-Movetis NV | ||
| Full Title: An Open-label, Randomized, Crossover, Reader-blinded Study To Investigate the Effect of Prucalopride and Polyethylene Glycol 3350 on Colon Motility with Intraluminal Manometry in Subjects with C... | ||
| Medical condition: Chronic Constipation | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: BE (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2012-004109-28 | Sponsor Protocol Number: GA1211 | Start Date*: 2013-01-18 |
| Sponsor Name:Reckitt Benckiser Healthcare (UK) Ltd | ||
| Full Title: A randomised, 4 way crossover, double blind, placebo controlled pilot study in patients with reflux symptoms, to assess suppression of gastro-oesophageal reflux by ‘Gaviscon Double Action Mint ’ us... | ||
| Medical condition: This study assesses suppression of gastro-oesophageal reflux of Gaviscon in patients with gastro-oesophageal reflux disease. | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: GB (Prematurely Ended) | ||
| Trial results: View results | ||
| EudraCT Number: 2010-021463-32 | Sponsor Protocol Number: IC-01-02-02-007 | Start Date*: 2011-02-24 | |||||||||||
| Sponsor Name:Innovacell Biotechnologie AG | |||||||||||||
| Full Title: Skeletal muscle-derived cell implantation for the treatment of fecal incontinence: a multicenter, randomized, double-blind, placebocontrolled, parallel-group, dose-finding clinical study | |||||||||||||
| Medical condition: Fecal incontinence in female and male patients with external anal sphincter weakness or sphincter damage. | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: AT (Prematurely Ended) DE (Prematurely Ended) SE (Prematurely Ended) CZ (Prematurely Ended) GB (Prematurely Ended) SI (Prematurely Ended) BG (Prematurely Ended) | |||||||||||||
| Trial results: View results | |||||||||||||
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
| Download Options: | |
|---|---|
| Number of Trials to download: | |
| Download Content: | |
| Download Format: | |
| Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. | |
Query did not match any studies.
